The epidermal growth factor receptors and their family of ligands: their putative role in atherogenesis (Q24312466)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16076471%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

review article

1 reference

title

The epidermal growth factor receptors and their family of ligands: their putative role in atherogenesis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16076471%20AND%20SRC:MED&resulttype=core&format=json

epidermal growth factor receptor

5 January 2020

main subject

1 reference

protein tyrosine kinase activity

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

author

Helmout Modjtahedi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16076471%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Alys C Dreux

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16076471%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

David J Lamb

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16076471%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Gordon A A Ferns

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16076471%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

English

0 references

publication date

1 August 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16076471%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16076471%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

186

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16076471%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

38-53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16076471%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16076471%20AND%20SRC:MED&resulttype=core&format=json

Overexpression of epidermal growth factor receptor restricted to macrophages in uveal melanoma

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

High glucose and hyperosmolarity increase heparin-binding epidermal growth factor-like growth factor (HB-EGF) production in cultured human aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Targeting of cells expressing wild-type EGFR and type-III mutant EGFR (EGFRvIII) by anti-EGFR MAb ICR62: a two-pronged attack for tumour therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Functional analysis of the ligand binding site of EGF-receptor utilizing chimeric chicken/human receptor molecules.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Presence of epidermal growth factor receptors and influence of epidermal growth factor on proliferation and aging in cultured smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Spatial organization of EGF receptor transmodulation by PDGF

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

EGF family ligand-dependent phenotypic modulation of smooth muscle cells through EGF receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Activation mechanism of solubilized epidermal growth factor receptor tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Increased plasma HB-EGF associated with obesity and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Involvement of ADAM9 in multinucleated giant cell formation of blood monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Evidence for the expression of the EGF receptor on human monocytic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Comparative genomic sequence analysis and isolation of human and mouse alternative EGFR transcripts encoding truncated receptor isoforms.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Detection and cellular localization of heparin-binding epidermal growth factor-like growth factor mRNA and protein in human atherosclerotic tissue

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Development of the epidermal growth factor receptor inhibitor Tarceva (OSI-774).

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Characterization of binding and receptors for epidermal growth factor in smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Production of macrophage-activated killer cells for targeting of glioblastoma cells with bispecific antibody to FcgammaRI and the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Molecular therapy of head and neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Epidermal growth factor receptor expression in demented elderly: localization to vascular endothelial cells of brain, pituitary and skin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Hydrogen peroxide preferentially enhances the tyrosine phosphorylation of epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Macrophages, macrophage foam cells, and eccentric intimal thickening in the coronary arteries of young children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

High-density lipoprotein reduces epidermal growth factor-induced DNA synthesis in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

The distribution of intimal white blood cells in the normal rabbit aorta

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Protein kinase C phosphorylation at Thr 654 of the unoccupied EGF receptor and EGF binding regulate functional receptor loss by independent mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Induction of transforming growth factor-alpha in activated human alveolar macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Signal transduction by receptors with tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Dimerization of cell surface receptors in signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

The MAP kinase cascade is essential for diverse signal transduction pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Regulation of signal transduction and signal diversity by receptor oligomerization

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

EGF mediates monocyte chemotaxis and macrophage proliferation and EGF receptor is expressed in atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Preclinical and clinical evaluations of ABX-EGF, a fully human anti-epidermal growth factor receptor antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Physiological and pathological actions of sphingosine 1-phosphate.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Solution structure of betacellulin, a new member of EGF-family ligands

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Amphiregulin is a potent mitogen for the vascular smooth muscle cell line, A7r5.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Mechanism of action of erbB tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Epidermal growth factor receptor: mechanisms of activation and signalling.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Neuregulins: functions, forms, and signaling strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

1 reference

7 January 2021

Trafficking of the ErbB receptors and its influence on signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Identification of an intracellular domain of the EGF receptor required for high-affinity binding of EGF.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Epidermal growth factor receptor-related protein: a potential therapeutic agent for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Immunohistochemical localization of Betacellulin, a member of epidermal growth factor family, in atherosclerotic plaques of human aorta

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

The physiology of transforming growth factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Cell signaling by receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

A central role of EGF receptor transactivation in angiotensin II -induced cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

The ADAM gene family: surface proteins with adhesion and protease activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Activation of extracellular signal-regulated kinase mediates bombesin-induced mitogenic responses in prostate cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Regulation of tyrosine kinase cascades by G-protein-coupled receptors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Epidermal growth factor receptors: critical mediators of multiple receptor pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Growth factor receptor signalling: location, location, location

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Structure-function and biological role of betacellulin

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

1 reference

7 January 2021

Heparin-binding EGF-like growth factor: a juxtacrine growth factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Epidermal growth factor and transforming growth factor alpha bind differently to the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Cholesterol levels modulate EGF receptor-mediated signaling by altering receptor function and trafficking

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Multiple metalloproteinases process protransforming growth factor-alpha (proTGF-alpha).

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Activation of epidermal growth factor receptor by epidermal growth factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

The type III epidermal growth factor receptor mutation. Biological significance and potential target for anti-cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Autophosphorylation sites on the epidermal growth factor receptor.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

A Grb2-associated docking protein in EGF- and insulin-receptor signalling

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Ligands for ErbB-family receptors encoded by a neuregulin-like gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Functional rafts in cell membranes

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

ZD6474--a novel inhibitor of VEGFR and EGFR tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Thrombin-induced p38 mitogen-activated protein kinase activation is mediated by epidermal growth factor receptor transactivation pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Meltrin alpha cytoplasmic domain interacts with SH3 domains of Src and Grb2 and is phosphorylated by v-Src

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Epidermal growth factor receptor activation is localized within low-buoyant density, non-caveolar membrane domains

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor family

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Role of membrane-anchored heparin-binding epidermal growth factor-like growth factor and CD9 on macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

CI-1033, an irreversible pan-erbB receptor inhibitor and its potential application for the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Growth factors from murine sarcoma virus-transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Amphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Ligand-induced stimulation of epidermal growth factor receptor mutants with altered transmembrane regions

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Cell proliferation in human coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Cell-cell adhesion mediated by binding of membrane-anchored transforming growth factor alpha to epidermal growth factor receptors promotes cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4+ and CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Epiregulin is a potent vascular smooth muscle cell-derived mitogen induced by angiotensin II, endothelin-1, and thrombin

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Epiregulin. A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Platelet-activating factor stimulates transcription of the heparin-binding epidermal growth factor-like growth factor in monocytes. Correlation with an increased kappa B binding activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Folding and stability of the Z and S(iiyama) genetic variants of human alpha1-antitrypsin

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Role of tyrosine kinase activity of epidermal growth factor receptor in the lysophosphatidic acid-stimulated mitogen-activated protein kinase pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Carbachol stimulates transactivation of epidermal growth factor receptor and mitogen-activated protein kinase in T84 cells. Implications for carbachol-stimulated chloride secretion

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Vascular endothelial growth factor induces heparin-binding epidermal growth factor-like growth factor in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Dimerization of the extracellular domain of the receptor for epidermal growth factor containing the membrane-spanning segment in response to treatment with epidermal growth factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Second cysteine-rich region of epidermal growth factor receptor contains targeting information for caveolae/rafts

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Cloning and biological activity of epigen, a novel member of the epidermal growth factor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Epidermal growth factor (EGF) receptor kinase-independent signaling by EGF.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

beta-Migrating very low density lipoprotein (beta VLDL) activates smooth muscle cell mitogen-activated protein (MAP) kinase via G protein-coupled receptor-mediated transactivation of the epidermal growth factor (EGF) receptor: effect of MAP kinase a

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Sequestration of epidermal growth factor receptors in non-caveolar lipid rafts inhibits ligand binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Tobacco Smoke-induced Lung Cell Proliferation Mediated by Tumor Necrosis Factor α-converting Enzyme and Amphiregulin

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Epidermal Growth Factor Induction of Phenotype-dependent Cell Cycle Arrest in Vascular Smooth Muscle Cells Is through the Mitogen-activated Protein Kinase Pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Factor Xa induces mitogenesis of vascular smooth muscle cells via autocrine production of epiregulin

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Metalloproteinase expression in PMA-stimulated THP-1 cells. Effects of peroxisome proliferator-activated receptor-gamma (PPAR gamma) agonists and 9-cis-retinoic acid.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

ADAM binding protein Eve-1 is required for ectodomain shedding of epidermal growth factor receptor ligands

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Role of sphingosine-1-phosphate phosphatase 1 in epidermal growth factor-induced chemotaxis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Epidermal growth factor receptor transactivation mediates tumor necrosis factor-induced hepatocyte replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Recruitment of epidermal growth factor receptors into coated pits requires their activated tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Employment of the epidermal growth factor receptor in growth factor-independent signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Lipid rafts make for slippery platforms

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Control of proliferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor, and thrombin

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Synergistic action of angiotensin II, insulin-like growth factor-I, and transforming growth factor-beta on platelet-derived growth factor-BB, basic fibroblastic growth factor, and epidermal growth factor-induced DNA synthesis in vascular smooth musc

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

The m1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Two EGF molecules contribute additively to stabilization of the EGFR dimer

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Signal characteristics of G protein-transactivated EGF receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

The ErbB signaling network: receptor heterodimerization in development and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Developing inhibitors of the epidermal growth factor receptor for cancer treatment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Epidermal growth factor and transforming growth factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

The biologic effects of C225, a chimeric monoclonal antibody to the EGFR, on human prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Endothelin-1 stimulates DNA synthesis of vascular smooth-muscle cells through transactivation of epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Single-strand conformation polymorphism analysis of the epidermal growth factor receptor at codon 497.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Tissue inhibitors of metalloproteinases and metalloproteinases in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Epidermal growth factor is a motility factor for microglial cells in vitro: evidence for EGF receptor expression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

EGFR transactivation in the regulation of SMC function.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Epidermal Growth Factor: Identification of a New Hormone in Human Urine

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

A Heparin-Binding Growth Factor Secreted by Macrophage-Like Cells That Is Related to EGF

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Structure and function of human amphiregulin: a member of the epidermal growth factor family

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Identification of heregulin, a specific activator of p185erbB2

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

An essential role for ectodomain shedding in mammalian development

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Betacellulin: a mitogen from pancreatic beta cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Transforming growth factor alpha in arterioles: cell surface processing of its precursor by elastases

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

The heparin-binding domain of amphiregulin necessitates the precursor pro-region for growth factor secretion

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

A novel positive feedback loop mediated by the docking protein Gab1 and phosphatidylinositol 3-kinase in epidermal growth factor receptor signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Receptor heterodimerization: essential mechanism for platelet-derived growth factor-induced epidermal growth factor receptor transactivation

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Epidermal Growth Factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Protein-tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Signalling by receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Membrane-anchored growth factors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Function and regulation of ras.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

The caveolae membrane system

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Heterologous desensitization of EGF receptors and PDGF receptors by sequestration in caveolae

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Regulation of vascular angiotensin II receptors by EGF

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Modification of breast cancer risk in young women by a polymorphic sequence in the egfr gene.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

United States Food and Drug Administration Drug Approval summary: Gefitinib (ZD1839; Iressa) tablets

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

TaqI polymorphism of the epidermal growth factor receptor gene in Caucasoids and Japanese

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Regulation of differentiated properties and proliferation of arterial smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Response of atherosclerotic intimal smooth muscle cells to epidermal growth factor in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Localization of CD9, an enhancer protein for proheparin-binding epidermal growth factor-like growth factor, in human atherosclerotic plaques: possible involvement of juxtacrine growth mechanism on smooth muscle cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Remnant Lipoprotein-Induced Smooth Muscle Cell Proliferation Involves Epidermal Growth Factor Receptor Transactivation

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Localization of heparin-binding epidermal growth factor-like growth factor in human coronary arteries. Possible roles of HB-EGF in the formation of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Betacellulin and amphiregulin induce upregulation of cyclin D1 and DNA synthesis activity through differential signaling pathways in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Heparin-binding epidermal growth factor-like growth factor regulates fibroblast growth factor-2 expression in aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Lysophosphatidylcholine increases expression of heparin-binding epidermal growth factor-like growth factor in human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Early phase I data on an irreversible pan-erb inhibitor: CI-1033. What did we learn?

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Characterization of epidermal growth factor receptors in cultured vascular smooth muscle cells of rat aorta

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Epidermal growth factor receptor tyrosine kinase inhibitors in late stage clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Epidermal growth factor receptor inhibition strategies in oncology

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Monoclonal antibodies targeting the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

Small molecules with EGFR-TK inhibitor activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

IL-8-mediated cell migration in endothelial cells depends on cathepsin B activity and transactivation of the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2005.06.038

7 January 2021

10.1016/J.ATHEROSCLEROSIS.2005.06.038

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

255121

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16076471%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

255121

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

2 references

255121